Ads
related to: sanofi pharmaceuticals- Careers
Join our Mission to Improve
the Lives of Patients.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- Sign Up
Sign Up for Updates, News
and Much More.
- Careers
Search results
J&J gains another bispecific antibody with $1.25B skin drug buy
BioPharma Dive via Yahoo Finance· 6 days agoThe drug targets two proteins... and IL-31, that are linked to inflammatory diseases. Dive Insight:...
3 High-Yielding Dividend Stocks On Euronext Paris With Up To 4.2% Yield
Simply Wall St. via Yahoo Finance· 6 days agoIn recent trading sessions, France's CAC 40 Index has experienced a modest decline of 0.89%,...
The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.
Investor's Business Daily· 6 days agoLeerink Partners analyst Joseph Schwartz compared the market potential for Insmed's brensocatib to...
Novartis sues Maryland over law prohibiting restrictions on 340B drugs
Becker’s Hospital Review· 3 days ago"Novartis sues Maryland over new law restricting 340B drug pricing program, citing conflict with federal law and potential harm to constitutional rights."
Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in...
FOX 23 News Albany· 7 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
France against Servier selling generics unit Biogaran, PM says
Reuters· 5 days agoThe French government has told drugmaker Servier it is against any sale of its generics subsidiary...
Quadruplet Regimens Have Become Standard for Multiple Myeloma
MedPage Today· 4 days agoWhile triplet regimens were once standard for newly diagnosed multiple myeloma, more recent studies...
Intellia’s CRISPR drug shows promise against hereditary angioedema in early-stage trial - Boston...
The Business Journals· 1 day agoBack in 2021, Intellia made history when it successfully edited DNA inside the human body, working...
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are...
Yucaipa News Mirror· 2 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...
Agios cashes in on cancer drug again with $905M Royalty Pharma deal
BioPharma Dive via Yahoo Finance· 6 days agoThe deal involves royalties for a brain cancer drug Agios previously sold off and that Royalty...